BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30056567)

  • 21. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.
    Effenberger KE; Borgen E; Eulenburg CZ; Bartkowiak K; Grosser A; Synnestvedt M; Kaaresen R; Brandt B; Nesland JM; Pantel K; Naume B
    Breast Cancer Res Treat; 2011 Feb; 125(3):729-38. PubMed ID: 20449649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients.
    Hoffmann K; Kerner C; Wilfert W; Mueller M; Thiery J; Hauss J; Witzigmann H
    World J Gastroenterol; 2007 Jan; 13(2):257-63. PubMed ID: 17226905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.
    Heiss MM; Simon EH; Beyer BC; Gruetzner KU; Tarabichi A; Babic R; Schildberg FW; Allgayer H
    J Clin Oncol; 2002 Apr; 20(8):2005-16. PubMed ID: 11956259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
    Jauch KW; Heiss MM; Gruetzner U; Funke I; Pantel K; Babic R; Eissner HJ; Riethmueller G; Schildberg FW
    J Clin Oncol; 1996 Jun; 14(6):1810-7. PubMed ID: 8656249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer.
    Majima T; Ichikura T; Takayama E; Chochi K; Mochizuki H
    Jpn J Clin Oncol; 2000 Nov; 30(11):499-503. PubMed ID: 11155920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer.
    Wiedswang G; Borgen E; Schirmer C; Kåresen R; Kvalheim G; Nesland JM; Naume B
    Int J Cancer; 2006 Apr; 118(8):2013-9. PubMed ID: 16287086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
    Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
    Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of isolated tumour cells in the blood and bone marrow of patients with gastric cancer by combined sorting, isolation and determination of MAGE-1, -2 mRNA expression.
    Szatanek R; Drabik G; Baran J; Kolodziejczyk P; Kulig J; Stachura J; Zembala M
    Oncol Rep; 2008 Apr; 19(4):1055-60. PubMed ID: 18357396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of cytokeratin-positive bone marrow cells of gastric cancer patients.
    Gretschel S; Schick C; Schneider U; Estevez-Schwarz L; Bembenek A; Schlag PM
    Ann Surg Oncol; 2007 Feb; 14(2):373-80. PubMed ID: 17080240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
    Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
    Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients.
    Pierga JY; Deneux L; Bonneton C; Vincent-Salomon A; Nos C; Anract P; Magdelénat H; Pouillart P; Thiery JP
    Int J Biol Markers; 2004; 19(1):23-31. PubMed ID: 15077923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival.
    Soeth E; Grigoleit U; Moellmann B; Röder C; Schniewind B; Kremer B; Kalthoff H; Vogel I
    J Cancer Res Clin Oncol; 2005 Oct; 131(10):669-76. PubMed ID: 16136352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer.
    Tewes M; Kasimir-Bauer S; Welt A; Schuler M; Kimmig R; Aktas B
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):87-92. PubMed ID: 25108406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
    Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
    Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
    Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
    Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.
    Janni W; Gastroph S; Hepp F; Kentenich C; Rjosk D; Schindlbeck C; Dimpfl T; Sommer H; Braun S
    Cancer; 2000 May; 88(10):2252-9. PubMed ID: 10820346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR.
    Soeth E; Vogel I; Röder C; Juhl H; Marxsen J; Krüger U; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1997 Aug; 57(15):3106-10. PubMed ID: 9242433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumour cells and survival of patients with gastric cancer.
    Pituch-Noworolska A; Kolodziejczyk P; Kulig J; Drabik G; Szczepanik A; Czupryna A; Popiela T; Zembala M
    Anticancer Res; 2007; 27(1B):635-40. PubMed ID: 17348453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.